Xyosted 50 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJE18
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,780
Award facts
- Contract value 100% obligated
- $1,780.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xyosted 50 mg/0.5 ml auto-injector units, valued at $1,780.19. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The order will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open procurement.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, supplies a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems. Xyosted, a testosterone replacement therapy auto-injector, represents the type of specialized pharmaceutical commodity the contractor regularly delivers through its DLA relationship. As a prime vendor under the global pharmaceutical support vehicle, AmerisourceBergen continues to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio and competitive award history demonstrate its established capability to meet federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FJE18?
SPE2DB25FJE18 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FJE18 worth?
The government has obligated $1,780 on SPE2DB25FJE18.
Is contract SPE2DB25FJE18 an order under another contract?
Yes. SPE2DB25FJE18 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJE18 competed?
The extent of competition for SPE2DB25FJE18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award